Affinity-matured MICA antibodies and their applications

JP7854469B2Active Publication Date: 2026-05-01HEFEI TG IMMUNOPHARMA CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
HEFEI TG IMMUNOPHARMA CO LTD
Filing Date
2024-05-02
Publication Date
2026-05-01

Smart Images

  • Figure 0007854469000009
    Figure 0007854469000009
  • Figure 0007854469000010
    Figure 0007854469000010
  • Figure 0007854469000011
    Figure 0007854469000011
Patent Text Reader

Abstract

To provide affinity matured MICA antibodies and applications thereof, more specifically, antibodies or antigen binding fragments thereof, nucleic acid molecules, expression vectors, methods for preparing the antibodies or antigen binding fragments thereof, recombinant cells, compositions and uses thereof, pharmaceuticals and uses thereof.SOLUTION: The invention presents an antibody or antigen binding fragment thereof and uses thereof. The antibody or antigen binding fragment thereof comprises heavy chain variable region CDR1, CDR2 and CDR3 each having a specific amino acid sequence or an amino acid sequence having at least 80% identity to the specific sequence, and light chain variable region CDR1, CDR2 and CDR3 each having a specific amino acid sequence or an amino acid sequence having at least 80% identity to the specific sequence. The antibody or antigen binding fragment thereof binds to human and monkey MICA protein with high affinity and promotes the tumor killing by PBMC (human peripheral blood mononuclear cell).SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Antibodies and uses thereof

    CN114369162A